JS

Josh Stevens

Advisor to the CEO of Healthrageous

San Francisco, California

Overview 

Josh Stevens is a seasoned Technology & Healthcare Executive with a strong track record in deal closure and revenue generation. He currently serves as an Independent Board Member and has held leadership roles at companies like Welltok and Ticketmaster, showcasing expertise in strategic leadership and international M&A. Highlights of Josh's career include serving as CEO of Welltok, where he led the company through growth and acquisition, as well as his role as SVP Corporate Development at Ticketmaster, contributing to successful acquisitions.

Work Experience 

  • CEO

    2025 - Current

    • Beckley Clinical is the market leader in value-based behavioral healthcare services, with a specialization in psychedelic-assisted therapy for anxiety, depression, PTSD, and hospice care. • Beckley enables patient access through Commercial, Medicare & Medicaid insurance coverage, expanding behavioral health reach and impact. psychedelic-assisted therapy.

  • Interim CEO

    2024 - 2024

  • Managing Partner

    2012

    Healthcare strategy & management consulting. Emphasis on PE backed companies with an emphasis on value-based-care, population health, food-as-medicine, and cardio-metabolic chronic-condition management.

  • Chair, Pension Fund Audit Committee

    2018

    Member of the Investment, Audit, and Compliance committees of the Board of Directors. The Board of Pensions administers the Healthcare Benefits and Pension funds totaling $12 billion.

The Board of Pensions of the Presbyterian Church (U.S.A.) is a nonprofit company that offers financial plans and solutions.

  • Healthcare & Health IT Investments

    2017 - 2023

    Healthcare & Health IT

Crosslink Capital partners with founders that are market disrupters and category creators, typically at the Seed-Series A stage.

  • President & Chief Growth Officer

    2017 - 2022

    DayTwo's outcomes-based model uses a gut microbiome profile to enable a path to remission for patients with type 2 diabetes. DayTwo serves primarily employers and payers to deliver personalized care plans and care coordination that enables medication reduction, lower A1C, and improved weight management.

DayTwo is the leader in precision nutrition for metabolic disease using gut microbiome science, AI and virtual clinical support.

Raised $90,414,821.00 from Poalim Equity, Yair Schindel, La Maison Partners, Volta Circle, 10D, aMoon Fund, Jacky Abitbol, Micron Ventures, Cathay Innovation and Samsung NEXT.

  • CEO, Keas (Acquired by Virgin Pulse)

    2012 - 2016

Welltok is an enterprise SaaS company that delivers a healthcare consumer activation platform.

Raised $262,230,798.00 from TriZetto, Grupo SURA, Silicon Valley Bank, New Enterprise Associates, NF Trinity Capital, Veronorte, Future Fund, Bessemer Venture Partners, ITOCHU Corporation and Georgian.

  • CRO, YouSendIt (Acquired by OpenText & Western Digital)

    2008 - 2012

  • SVP Corporate Development, TicketsNow (Acquired by Ticketmaster)

    2007 - 2008

Ticketmaster is a ticket sales and distribution company that sells tickets for concerts, sports, and events.

  • GM e-Commerce

    1997 - 2007

AOL Lifestream is a web-based application that enables users to keep track of all their comments on social networking sites.

Raised $1,000,000,000.00 from Comcast Ventures and Google.

  • Corporate Finance

    1995 - 1997

Morgan Health is the healthcare investment arm of JPMorgan Chase.

Articles About Josh

Relevant Websites